Freyr Regulatory Radio
A podcast by Freyr Solutions
29 Episoade
-  Season 5: Episode 5 – Reporting Adverse Events Under MoCRAPublicat: 01.03.2024
-  Season 5: Episode 4 – Safety in Focus – MoCRA Safety SubstantiationPublicat: 01.03.2024
-  Season 5: Episode 3 – Mastering Product Listing: A Comprehensive Guide to MoCRA RequirementsPublicat: 01.03.2024
-  Season 5: Episode 2 – Untangling the Responsibilities of MoCRA Agents and RPsPublicat: 01.03.2024
-  Season 5: Episode 1 – MoCRA Facility Registration: What You Need to Know?Publicat: 01.03.2024
-  Season 4: Episode 5 - Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EUPublicat: 26.09.2023
-  Season 4: Episode 4 - Challenges in CMC Development of Biologics/BiosimilarsPublicat: 19.09.2023
-  Season 4: Episode 3 - CMC Requirements for Biologics/BiosimilarsPublicat: 12.09.2023
-  Season 4: Episode 2 - ICH Guidelines for CMC Development of Biologics/BiosimilarsPublicat: 05.09.2023
-  Season 4: Episode 1 - Introduction to Biologics/Biosimilars and Regulatory Pathways for Approval in the EUPublicat: 29.08.2023
-  Season 3: Episode 6 - Regulatory Lifecycle Management of Medicinal ProductsPublicat: 28.02.2023
-  Season 3: Episode 5 - Medicinal Products’ Intellectual PatentingPublicat: 21.02.2023
-  Season 3: Episode 4 - US FDA’s Facilitated Regulatory Pathway and Their SignificancePublicat: 14.02.2023
-  Season 3: Episode 3 - Procedures for Medicinal Products’ ApprovalPublicat: 07.02.2023
-  Season 3: Episode 2 - GDUFA & PDUFA GuidelinesPublicat: 31.01.2023
-  Season 3: Episode 1 - US Market Entry & Landscape In Regulatory AffairsPublicat: 24.01.2023
-  Season 2: Episode 6 - Pharma Advertising and Promotions: CanadaPublicat: 14.12.2022
-  Season 2: Episode 5 - Pharma Advertising and Promotions: MexicoPublicat: 07.12.2022
-  Season 2: Episode 4 - Pharma Advertising and Promotions: United KingdomPublicat: 30.11.2022
-  Season 2: Episode 3 - Pharma Advertising and Promotions: LithuaniaPublicat: 23.11.2022
Freyr is a leading, niche, full-service global Regulatory Solutions, and Services Company supporting, Large, Medium, and Small size global Life sciences companies, (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics | Food and Food Supplements | Chemicals) in their entire Regulatory value-chain; ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post- Approval / Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions.
